{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:39:54Z","timestamp":1790048394342,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273526"],"award-info":[{"award-number":["81273526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473268"],"award-info":[{"award-number":["81473268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anhui Provincial Key Scientific and Technological Project","award":["1301042212"],"award-info":[{"award-number":["1301042212"]}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["1308085MH145"],"award-info":[{"award-number":["1308085MH145"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.taap.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T07:20:56Z","timestamp":1468048856000},"page":"58-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis"],"prefix":"10.1016","volume":"306","author":[{"given":"Xing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2016.07.003_bb0005","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4161\/cc.26433","article-title":"Proliferative status regulates HDAC11 mRNA abundance in nontransformed fibroblasts","volume":"12","author":"Bagui","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.taap.2016.07.003_bb0010","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2016.07.003_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2016.07.003_bb0020","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/b703830p","article-title":"Isoform-selective histone deacetylase inhibitors","volume":"37","author":"Bieliauskas","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.taap.2016.07.003_bb0025","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.oraloncology.2008.08.011","article-title":"Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients","volume":"45","author":"Chang","year":"2009","journal-title":"Oral Oncol."},{"key":"10.1016\/j.taap.2016.07.003_bb0030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2222.2011.03931.x","article-title":"Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts","volume":"42","author":"Cho","year":"2012","journal-title":"Clin. Exp. Allergy J Br. Soc. Allergy Clin. Immunol."},{"key":"10.1016\/j.taap.2016.07.003_bb0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0016-5085(03)00666-8","article-title":"Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats","volume":"125","author":"Dooley","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2016.07.003_bb0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.gastro.2008.04.038","article-title":"Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage","volume":"135","author":"Dooley","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2016.07.003_bb0045","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"Ellis","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2016.07.003_bb0050","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2016.07.003_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007105","article-title":"Cytokines and fibrogenesis","volume":"19","author":"Friedman","year":"1999","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.taap.2016.07.003_bb0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis \u2014 overview","volume":"254","author":"Friedman","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2016.07.003_bb0065","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2016.07.003_bb0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2016.07.003_bb0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.taap.2016.07.003_bb0080","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1582-4934.2008.00262.x","article-title":"Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice","volume":"12","author":"Hamzavi","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.taap.2016.07.003_bb0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.taap.2016.07.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.146","article-title":"Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2016.07.003_bb0095","article-title":"Activation of mir-29a in activated hepatic stellate cells modulates its profibrogenic phenotype through inhibition of histone deacetylases 4","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2016.07.003_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","article-title":"Hepatic fibrosis","volume":"25","author":"Jiao","year":"2009","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.taap.2016.07.003_bb0105","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1530-0277.2012.01751.x","article-title":"Binge alcohol-induced microvesicular liver steatosis and injury are associated with down-regulation of hepatic Hdac 1, 7, 9, 10, 11 and up-regulation of Hdac 3","volume":"36","author":"Kirpich","year":"2012","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.taap.2016.07.003_bb0110","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2016.07.003_bb0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2013.07.015","article-title":"Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors","volume":"75","author":"Koppel","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2016.07.003_bb0120","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/emboj\/19.6.1176","article-title":"Acetylation: a regulatory modification to rival phosphorylation?","volume":"19","author":"Kouzarides","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.taap.2016.07.003_bb0125","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tips.2009.09.007","article-title":"HDAC2: a critical factor in health and disease","volume":"30","author":"Kramer","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.taap.2016.07.003_bb0130","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/bju.12812","article-title":"Silencing histone deacetylase 2 using small hairpin RNA induces regression of fibrotic plaque in a rat model of Peyronie's disease","volume":"114","author":"Kwon","year":"2014","journal-title":"BJU Int."},{"key":"10.1016\/j.taap.2016.07.003_bb0135","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1158\/0008-5472.CAN-13-3531","article-title":"Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2","volume":"74","author":"Lee","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2016.07.003_bb0140","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3892\/or.2015.4263","article-title":"HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population","volume":"34","author":"Ler","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.taap.2016.07.003_bb0145","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/msb.2013.33","article-title":"The HDAC interaction network","volume":"9","author":"Livyatan","year":"2013","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.taap.2016.07.003_bb0150","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis","volume":"305","author":"Mallat","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.taap.2016.07.003_bb0155","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.23334","article-title":"Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo","volume":"51","author":"Mannaerts","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.07.003_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055786","article-title":"Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29","volume":"8","author":"Mannaerts","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2016.07.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034236","article-title":"Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation\/hypoacetylation in the rat nucleus accumbens","volume":"7","author":"Martin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2016.07.003_bb0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1101\/gr.108803.110","article-title":"Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer","volume":"21","author":"Matsumura","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.taap.2016.07.003_bb0175","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.5858\/2007-131-1728-HSCALF","article-title":"Hepatic stellate cells and liver fibrosis","volume":"131","author":"Moreira","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.taap.2016.07.003_bb0180","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.510290328","article-title":"A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture","volume":"29","author":"Niki","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.07.003_bb0185","doi-asserted-by":"crossref","first-page":"F729","DOI":"10.1152\/ajprenal.00086.2009","article-title":"Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury","volume":"297","author":"Noh","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.taap.2016.07.003_bb0190","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27209","article-title":"Cylindromatosis gene CYLD regulates hepatocyte growth factor expression in hepatic stellate cells through interaction with histone deacetylase 7","volume":"60","author":"Pannem","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.07.003_bb0195","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies","volume":"50","author":"Popov","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2016.07.003_bb0200","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.taap.2016.07.003_bb0205","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2353\/ajpath.2010.100011","article-title":"Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis","volume":"177","author":"Qin","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2016.07.003_bb0210","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0168-8278(02)00275-1","article-title":"Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor","volume":"37","author":"Rombouts","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2016.07.003_bb0215","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1074\/jbc.M410078200","article-title":"Adipogenic transcriptional regulation of hepatic stellate cells","volume":"280","author":"She","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2016.07.003_bb0220","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/CS20120504","article-title":"Histone deacetylases as targets for treatment of multiple diseases","volume":"124","author":"Tang","year":"2013","journal-title":"Clin. Sci."},{"issue":"1073\u20131083","key":"10.1016\/j.taap.2016.07.003_bb0225","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2016.07.003_bb0230","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1872-034X.2011.00804.x","article-title":"Epigenetic cell fate regulation of hepatic stellate cells","volume":"41","author":"Tsukamoto","year":"2011","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"10.1016\/j.taap.2016.07.003_bb0235","first-page":"153","article-title":"Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease","volume":"12","author":"Wang","year":"2015","journal-title":"J. Geriatr. Cardiol. JGC"},{"key":"10.1016\/j.taap.2016.07.003_bb0240","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","article-title":"HDAC expression and clinical prognosis in human malignancies","volume":"280","author":"Weichert","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2016.07.003_bb0245","series-title":"Toxicology and Applied Pharmacology","article-title":"Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion","author":"Wu","year":"2015"},{"key":"10.1016\/j.taap.2016.07.003_bb0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0959-437X(03)00015-7","article-title":"Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression","volume":"13","author":"Yang","year":"2003","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.taap.2016.07.003_bb0255","first-page":"1788","article-title":"[Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. Tanpakushitsu kakusan koso","volume":"52","author":"Yoshida","year":"2007","journal-title":"Protein Nucleic Acid Enzym."},{"key":"10.1016\/j.taap.2016.07.003_bb0260","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/pmic.201300539","article-title":"SILAC-based quantitative proteomic analysis of secretome between activated and reverted hepatic stellate cells","volume":"14","author":"Zhang","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.taap.2016.07.003_bb0265","article-title":"Melittin restores PTEN expression by down-regulating HDAC2 in human hepatocelluar carcinoma HepG2 cells","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16301776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16301776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T22:22:28Z","timestamp":1656800548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X16301776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":53,"alternative-id":["S0041008X16301776"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2016.07.003","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}